Eikon Therapeutics Inc EIKN

US Biotechnology

$9.21 ▼ -4.26% ($-0.41)

🗓️ Earnings Next Week

Open $9.54

Prev Close $9.62

Day Range $8.98 – $9.66

52W Range $7.90 – $17.40

Market Cap $498.62M

Beta 2.13

EPS (TTM) $-8.47

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2026-02-05
Shares Out.	54,140,000
Website	eikontx.com/ ↗
Phone	13026587581
Employees	384
Net Income	-$83.0M
Total Assets	$850.8M
Total Liabilities	$300.2M
Equity	$550.7M

About Eikon Therapeutics Inc

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Eikon Therapeutics Inc is a publicly traded company under the ticker symbol EIKN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.